Barrow Neurological Institute begins Alzheimer’s clinical trials

Patients with early Alzheimer’s can now enroll in clinical trials at Barrow Neurological Institute using drugs originally developed for cancer and multiple sclerosis. The two trials will be using already existing drugs for two very different conditions.

The first trial will look at the effects of a bone cancer drug in those living with mild cognitive impairment. The second trial will involve a drug used to treat multiple sclerosis.

Dr. Marwan Sabbagh, a behavioral neurologist at Barrow’s Alzheimer’s and Memory Disorders Program joined “Arizona Horizon” to discuss the trials and the type of patients the institute is looking for.